Improving hypertension care in a large group-model MCO

American Journal of Health-System Pharmacy

Volumn 60, Issue 6, 2003, Pages 554-564

  Godley, Paul ^a   Nguyen, Anh ^b   Yokoyama, Krista ^c   Rohack, James ^a   Woodward, Billy ^a   Chiang, Tina ^d  

^a SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

^c Wellpoint Inc   (United States)

^d The Aequitas Group Inc   (United States)

Author keywords

Angiotensin convertingnzymeinhibitors; Calcium antagonists; Diabetes mellitus; Diuretics; Geriatrics; Hypertension; Hypotensive agents; Interventions; Managed care systems; Pharmacists; Quality assurance; Sympatholytic agents

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CARVEDILOL; CLONIDINE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; NITRATE; SPIRONOLACTONE; VERAPAMIL;

ADULT; AGED; AGING; ARTICLE; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CLINICAL PRACTICE; COMORBIDITY; CONTINUING EDUCATION; DIABETES MELLITUS; DRUG INDICATION; EVALUATION; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; MEDICAL RECORD; MONOTHERAPY; OUTCOMES RESEARCH; PATIENT CARE; PATIENT EDUCATION; PHARMACIST; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; THEORETICAL MODEL; COMPARATIVE STUDY; DISEASE MANAGEMENT; DRUG COMBINATION; HEALTH INSURANCE; HEALTH SERVICES RESEARCH; MIDDLE AGED; NONBIOLOGICAL MODEL; ORGANIZATION AND MANAGEMENT; STANDARD; UNITED STATES;

AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; DISEASE MANAGEMENT; DRUG THERAPY, COMBINATION; FEMALE; HEALTH SERVICES RESEARCH; HUMANS; HYPERTENSION; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; MODELS, ORGANIZATIONAL; PROGRAM EVALUATION; QUALITY ASSURANCE, HEALTH CARE; UNITED STATES;

EID: 0037444908     PISSN: 10792082     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajhp/60.6.554     Document Type: Article

References (23)

1. Levy D, Larson MG, Vasan RS et al. The progression from hypertension to congestive heart failure. JAMA. 1996; 275:1557-62.
2. 2001 Heart and stroke statistical update. Dallas, TX: American Heart Association; 2000.
3. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension. 1995; 25:305-13.
4. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med. 1997; 157: 2413-46.
5. 1999 World Health Organization - International Society of Hypertension guidelines for the management of hypertension. J Hypertens. 1999; 17:151-83.
6. American Diabetes Association. Treatment of hypertension in adults with diabetes. Diabetes Care. 2002; 25(suppl 1): S71-3.
7. Bakris GL, Williams M, Dworkin L et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. Am J Kidney Dis. 2000; 36:646-661.
8. Hunt SA, Baker DW, Chin MH et al. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). J Am Coll Cardiol. 2001; 38: 2101-13.
9. Godley P, Pham H, Rohack J et al. Opportunities for improving the quality of hypertension care in a managed care setting. Am J Health-Syst Pharm. 2001; 58:1728-33.
10. The state of managed care quality 2000. Washington, DC: National Committee for Quality Assurance; 2000.
11. Yokoyama KK, Doan QD, Godley PJ et al. Effect of physician profiles and academic detailing on cost and utilization of selective serotonin reuptake inhibitors. J Manage Care Pharm. 2002; 8:23-31.
12. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA. 1991; 265:3255-64.
13. Neutel JM. Low-dose antihypertensive combination therapy: its rationale and role in cardiovascular risk management. Am J Hypertens. 1999; 12:73S-9S.
14. Epstein M, Bakris G. Newer approaches to antihypertensive therapy. Use of fixedose combination therapy. Arch Intern Med. 1996; 156:1969-78.
15. Ruilope LM, Coca A. The role of combination erapy in the treatment of hypertension. Blood Press Suppl. 1998; 1:22-6.
16. Hilleman DE, Ryschon KL, Mohiuddin SM et al. Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation. J Hum Hypertens. 1999; 13:477-83.
17. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984; 6:592-9.
18. Hansson L, Zanchetti A, Carruthers SG et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet. 1998; 351:175-7562.
19. Neaton JD, Wentworth D. Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease. Overall findings and differences by age for 316,099 white men. Arch Intern Med. 1992; 152:56-64.
20. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998; 317:703-13.
21. George PB, Tobin KJ, Corpus RA et al. Treatment of cardiac risk factors in diabetic patients: how well do we follow the guidelines? Am Heart J. 2001; 142:857-63.
22. The Hypertension in Diabetes Study Group. Hypertension in Diabetes Study (HDS): II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens. 1993; 11:319-25.
23. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993; 153:598-615.